Study S001832

A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02077946
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 1059
Start: 2014-02-10
Primary completion: 2014-09-03
Lead sponsor: Novo Nordisk A/S
Conditions: Diabetes; Diabetes Mellitus, Type 2
Interventions: DRUG:liraglutide; DRUG:sitagliptin
Results posted: FALSE
Secondary identifiers: OTHER:U1111-1151-9632

Registered primary outcomes

Percent (%) of patients achieving at least 1 %-point HbA1c (glycosylated haemoglobin) reduction [Day 0, Day 180]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0025920	Clinical Effectiveness of Liraglutide vs Sitagliptin on Glycemic Control and Body Weight in Patients with Type 2 Diabetes: A Retrospective Assessment in Sweden. Lind M, Diabetes therapy : research, treatment and education of diabetes and related disorders	2016	Nonrandomized study	PMID 27216947 DOI	cites ClinicalTrials.gov:NCT02077946; registry reference BACKGROUND:27216947